NORLAND MEDICAL SYSTEMS INC
10-Q, EX-27, 2000-11-13
LABORATORY ANALYTICAL INSTRUMENTS
Previous: NORLAND MEDICAL SYSTEMS INC, 10-Q, 2000-11-13
Next: BAB HOLDINGS INC, 8-K12G3, 2000-11-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          82,886
<SECURITIES>                                         0
<RECEIVABLES>                                1,560,941
<ALLOWANCES>                                   301,000
<INVENTORY>                                  2,558,327
<CURRENT-ASSETS>                             4,338,688
<PP&E>                                       1,014,730
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               5,353,418
<CURRENT-LIABILITIES>                        5,675,171
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        13,521
<OTHER-SE>                                 (1,481,679)
<TOTAL-LIABILITY-AND-EQUITY>                 5,353,418
<SALES>                                     10,650,378
<TOTAL-REVENUES>                            10,650,378
<CGS>                                        5,903,544
<TOTAL-COSTS>                               13,568,276
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             187,447
<INCOME-PRETAX>                            (9,003,219)
<INCOME-TAX>                                 4,118,507
<INCOME-CONTINUING>                       (13,121,726)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (13,121,726)
<EPS-BASIC>                                     (0.49)
<EPS-DILUTED>                                   (0.49)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission